2.58

13.91% 0.315

After Hours: 2.60 0.02 +0.78%

Cypherpunk Technologies Inc (CYPH)

Overview News Price History Discussions Forecast

Cypherpunk Technologies Inc stock is traded at $2.58, with a volume of 10.49M. It is up +13.91% in the last 24 hours and up +300.62% over the past month. Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Previous Close:

$2.265

Open:

$2.26

24h Volume:

10.49M

Relative Volume:

1.98

Market Cap:

$278.03M

Revenue:

Net Income/Loss:

$-56.91M

P/E Ratio:

-150.00

EPS:

-0.0172

Net Cash Flow:

$-133.85M

1W Performance:

+6.61%

1M Performance:

+300.62%

6M Performance:

+344.83%

1Y Performance:

+0.00%

1-Day Range:

$2.23

$2.61

1-Week Range:

$2.175

$3.225

52-Week Range:

$0.4913

$3.6999

Cypherpunk Technologies Inc Stock (CYPH) Company Profile

Name

Cypherpunk Technologies Inc

Sector

Healthcare (1068)

Industry

Biotechnology (598)

Phone

617 252 4343

Address

47 THORNDIKE STREET, CAMBRIDGE

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

CYPH's Discussions on Twitter

Compare CYPH vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CYPH Cypherpunk Technologies Inc	2.58	244.09M	0	-56.91M	-133.85M	-0.0172
VRTX Vertex Pharmaceuticals Inc	519.51	130.64B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	793.74	80.46B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	990.54	61.58B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	146.69	57.48B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	205.11	43.68B	742.00K	-1.37B	-1.07B	-7.0731

Cypherpunk Technologies Inc Stock (CYPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-29-25	Downgrade	H.C. Wainwright	Buy → Neutral
Jan-29-25	Downgrade	Robert W. Baird	Outperform → Neutral
Jun-28-24	Initiated	Rodman & Renshaw	Buy
Oct-04-21	Initiated	Mizuho	Buy
Jun-04-21	Resumed	Robert W. Baird	Outperform
Jun-29-20	Initiated	Piper Sandler	Overweight
Feb-11-20	Initiated	Robert W. Baird	Outperform
Nov-15-19	Downgrade	Raymond James	Outperform → Mkt Perform
Sep-13-19	Resumed	Raymond James	Outperform
Mar-07-17	Initiated	Ladenburg Thalmann	Buy

View All

Cypherpunk Technologies Inc Stock (CYPH) Latest News

Sep 10, 2026

Cantor Fitzgerald Maintains Cypherpunk Technologies(CYPH.US) With Buy Rating, Raises Target Price to $4.9 - Moomoo

Sep 10, 2026

CYPH Stock Pulls Back As Volatile Rally Pauses - timothysykes.com

Sep 10, 2026

CYPH Stock Pulls Back As Volatile Rally Tests Strong Balance Sheet - StocksToTrade

Sep 10, 2026

CYPH Maintains Overweight Rating -- Price Target Raised to $4.90 by Cantor Fitzgerald - GuruFocus

Sep 10, 2026

Sep 09, 2026

Cypherpunk Technologies Inc. (NASDAQ: CYPH) Share Price, CYPH Stock News, CYPH Share Price & Updates - kalkine.ca

Sep 03, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Sep 03, 2026

The Next Positive Sentiment… - Moomoo

Sep 03, 2026

Sep 02, 2026

Nasdaq listing risk eases for Cypherpunk (Nasdaq: CYPH) - Stock Titan

Sep 02, 2026

Aug 29, 2026